Press Releases

    • FEB 17 2015

    Article in Cancer Research Identifies Biomarkers and Combination Therapies that Hone Path to ONC201 Clinical Success

    Hummelstown, PA (February 16, 2015) – Oncoceutics, Inc. announced the publication of an article in the journal Cancer Research that describes the identification of several predictive markers of ONC201 response in tumor cells and promising drug combinations that may be investigated in future combinatorial clinical studies. Large genetic and pharmacological screens were conducted with ONC201

    • FEB 10 2015

    Oncoceutics to Present at the Leerink Global Healthcare Conference

    Hummelstown, PA (February 9, 2015) – Oncoceutics, Inc., a drug discovery and development company targeting the most potent suppressor pathways in human cancer, announced today that Wolfgang Oster, M.D., Ph.D., Chief Executive Officer, will present a corporate overview at the 2015 Leerink Global Healthcare Conference on Thursday, February 12, 2015, at 1:25 pm ET, at